US Immunodiagnostics Market Database 2024: Supplier Shares, Volume, Sales, Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests 2023-2028
July 22, 2024 05:55 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "2024 US Immunodiagnostics Market Database - Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical...
South Korea Immunodiagnostics Market Database 2024: Supplier Shares, Volume, Sales, and Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests 2023-2028
July 22, 2024 05:53 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "2024 South Korea Immunodiagnostics Market Database - Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer,...
Comprehensive 2024 Immunodiagnostics Market Database Unveiled for 38 European Countries
June 04, 2024 04:06 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "2024 Europe Immunodiagnostics Market Database for 38 Countries - Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs,...
2024 Ireland Immunodiagnostics Market Database: Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
June 03, 2024 04:09 ET
|
Research and Markets
Dublin, June 03, 2024 (GLOBE NEWSWIRE) -- The "2024 Ireland Immunodiagnostics Market Database - Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical...
United States Sex Reassignment Hormone Therapy Research Report 2024 Featuring Viatris, AbbVie, ASCEND Therapeutics, Pfizer, Eli Lilly and Co, Novartis, Endo International
May 30, 2024 04:13 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "United States Sex Reassignment Hormone Therapy Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
February 05, 2024 08:50 ET
|
Mangoceuticals, Inc.
The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (a $498 value) for First 1,000 Subscribers Dallas, Texas,...
Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast to 2028
January 24, 2024 13:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
United States Sex Reassignment Hormone Therapy Research Report 2023: Market to Reach $2.23 Billion by 2030 - Supportive Regulations and Novel Therapies Propel Expansion
December 11, 2023 09:33 ET
|
Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "U.S. Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type...
Female Infertility Treatment Drives Demand for Human Chorionic Gonadotropin Products
September 21, 2023 08:03 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Human Chorionic Gonadotropin Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's...
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...